149 related articles for article (PubMed ID: 28917649)
1. Evaluation of novel
Xu J; Feng C; Miao Y
Bioorg Med Chem Lett; 2017 Oct; 27(20):4647-4651. PubMed ID: 28917649
[TBL] [Abstract][Full Text] [Related]
2. Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides.
Guo H; Hathaway H; Royce ME; Prossnitz ER; Miao Y
Bioorg Med Chem Lett; 2013 Oct; 23(20):5484-7. PubMed ID: 24018188
[TBL] [Abstract][Full Text] [Related]
3. Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides.
Lu J; Hathaway HJ; Royce ME; Prossnitz ER; Miao Y
Bioorg Med Chem Lett; 2014 Feb; 24(3):725-30. PubMed ID: 24418777
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.
Guo H; Lu J; Hathaway H; Royce ME; Prossnitz ER; Miao Y
Bioconjug Chem; 2011 Aug; 22(8):1682-9. PubMed ID: 21749045
[TBL] [Abstract][Full Text] [Related]
5. A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.
Guo H; Gallazzi F; Sklar LA; Miao Y
Bioorg Med Chem Lett; 2011 Sep; 21(18):5184-7. PubMed ID: 21821417
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a New
Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
[TBL] [Abstract][Full Text] [Related]
7. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
8.
Masteri Farahani A; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.
Lee JJ; Shetty D; Lee YS; Kim SE; Kim YJ; Hong MK; Son JY; Jeong JM
Nucl Med Biol; 2012 Apr; 39(3):325-33. PubMed ID: 22136890
[TBL] [Abstract][Full Text] [Related]
11. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
12. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2010 Mar; 51(3):418-26. PubMed ID: 20150256
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of
Huang S; Li H; Han Y; Fu L; Ren Y; Zhang Y; Li Y; Sun P; Wang M; Wu H; Wang Q; Hu K
Contrast Media Mol Imaging; 2019; 2019():5635269. PubMed ID: 30983920
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.
Carlucci G; Ananias HJ; Yu Z; Hoving HD; Helfrich W; Dierckx RA; Liu S; de Jong IJ; Elsinga PH
Mol Pharm; 2013 May; 10(5):1716-24. PubMed ID: 23590837
[TBL] [Abstract][Full Text] [Related]
16. Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2011 Apr; 52(4):608-16. PubMed ID: 21421725
[TBL] [Abstract][Full Text] [Related]
17. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA
J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685
[TBL] [Abstract][Full Text] [Related]
18. Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Guo H; Shenoy N; Gershman BM; Yang J; Sklar LA; Miao Y
Nucl Med Biol; 2009 Apr; 36(3):267-76. PubMed ID: 19324272
[TBL] [Abstract][Full Text] [Related]
19. Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice.
Ho CL; Chen LC; Lee WC; Chiu SP; Hsu WC; Wu YH; Yeh CH; Stabin MG; Jan ML; Lin WJ; Lee TW; Chang CH
Cancer Biother Radiopharm; 2009 Aug; 24(4):435-43. PubMed ID: 19694578
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
